rethinkPeptides Search
Menu
Research citation

The efficacy and safety of danuglipron and orforglipron in patients with type 2 diabetes and obesity: a systematic review and meta-analysis.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

The efficacy and safety of danuglipron and orforglipron in patients with type 2 diabetes and obesity: a systematic review and meta-analysis.

Frontiers in endocrinology, 16, 1646956

Citation

Zhou, Jingjing; Wang, Fang; Li, Sen. (2025). The efficacy and safety of danuglipron and orforglipron in patients with type 2 diabetes and obesity: a systematic review and meta-analysis.. Frontiers in endocrinology, 16, 1646956. https://doi.org/10.3389/fendo.2025.1646956